Literature DB >> 27815166

Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy.

Wei Li1, Dongfei Liu1, Hongbo Zhang1, Alexandra Correia1, Ermei Mäkilä2, Jarno Salonen2, Jouni Hirvonen1, Hélder A Santos3.   

Abstract

Harsh conditions of the gastrointestinal tract hinder the oral delivery of many drugs. Developing oral drug delivery systems based on commercially available materials is becoming more challenging due to the demand for simultaneously delivering physicochemically different drugs for treating complex diseases. A novel architecture, namely nanotube-in-microsphere, was developed as a drug delivery platform by encapsulating halloysite nanotubes (HNTs) in a pH-responsive hydroxypropyl methylcellulose acetate succinate polymer using microfluidics. HNTs were selected as orally acceptable clay mineral and their lumen was enlarged by selective acid etching. Model drugs (atorvastatin and celecoxib) with different physicochemical properties and synergistic effect on colon cancer prevention and inhibition were simultaneously incorporated into the microspheres at a precise ratio, with atorvastatin and celecoxib being loaded in the HNTs and polymer matrix, respectively. The microspheres showed spherical shape, narrow particle size distribution and pH-responsive dissolution behavior. This nanotube/pH-responsive polymer composite protected the loaded drugs from premature release at pH⩽6.5, but allowed their fast release and enhanced the drug permeability, and the inhibition of colon cancer cell proliferation at pH 7.4. Overall, the nano-in-micro drug delivery composite fabricated by microfluidics is a promising and flexible platform for the delivery of multiple drugs for combination therapy. STATEMENT OF SIGNIFICANCE: Halloysite nanotubes (HNTs) are attracting increasing attention for drug delivery applications. However, conventional HNTs-based oral drug delivery systems are lack of the capability to precisely control the drug release at a desired site in the gastrointestinal tract. In this study, a nanotube-in-microsphere drug delivery platform is developed by encapsulating HNTs in a pH-responsive polymer using microfluidics. Drugs with different physicochemical properties and synergistic effect on colon cancer therapy were simultaneously incorporated in the microspheres. The prepared microspheres prevented the premature release of the loaded drugs after exposure to the harsh conditions of the gastrointestinal tract, but allowed their simultaneously fast release, and enhanced the drug permeability and the inhibition of colon cancer cell proliferation in response to the colon pH.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dual delivery; Halloysite nanotubes; Microfluidics; Oral delivery; pH responsive

Mesh:

Substances:

Year:  2016        PMID: 27815166     DOI: 10.1016/j.actbio.2016.10.042

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  16 in total

Review 1.  Halloysite nanotubes in analytical sciences and in drug delivery: A review.

Authors:  Meriem Fizir; Pierre Dramou; Nasiru Sintali Dahiru; Wang Ruya; Tao Huang; Hua He
Journal:  Mikrochim Acta       Date:  2018-07-25       Impact factor: 5.833

Review 2.  Basics to advances in nanotherapy of colorectal cancer.

Authors:  Ankita Tiwari; Shivani Saraf; Ankit Jain; Pritish K Panda; Amit Verma; Sanjay K Jain
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

3.  Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy.

Authors:  Nayab Tahir; Asadullah Madni; Alexandra Correia; Mubashar Rehman; Vimalkumar Balasubramanian; Muhammad Muzamil Khan; Hélder A Santos
Journal:  Int J Nanomedicine       Date:  2019-07-05

4.  Preparation and Characterization of Dentin Phosphophoryn-Derived Peptide-Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake.

Authors:  Patrícia Figueiredo; Mika H Sipponen; Kalle Lintinen; Alexandra Correia; Alexandros Kiriazis; Jari Yli-Kauhaluoma; Monika Österberg; Anne George; Jouni Hirvonen; Mauri A Kostiainen; Hélder A Santos
Journal:  Small       Date:  2019-05-06       Impact factor: 13.281

Review 5.  AFM Characterization of Halloysite Clay Nanocomposites' Superficial Properties: Current State-of-the-Art and Perspectives.

Authors:  Mariafrancesca Cascione; Valeria De Matteis; Francesca Persano; Stefano Leporatti
Journal:  Materials (Basel)       Date:  2022-05-10       Impact factor: 3.748

6.  Microfluidic synthesis of PLGA/carbon quantum dot microspheres for vascular endothelial growth factor delivery.

Authors:  Meisam Omidi; Mohadeseh Hashemi; Lobat Tayebi
Journal:  RSC Adv       Date:  2019-10-17       Impact factor: 4.036

Review 7.  Micro and nanoscale technologies in oral drug delivery.

Authors:  Samad Ahadian; Joel A Finbloom; Mohammad Mofidfar; Sibel Emir Diltemiz; Fatemeh Nasrollahi; Elham Davoodi; Vahid Hosseini; Ioanna Mylonaki; Sivakoti Sangabathuni; Hossein Montazerian; Kirsten Fetah; Rohollah Nasiri; Mehmet Remzi Dokmeci; Molly M Stevens; Tejal A Desai; Ali Khademhosseini
Journal:  Adv Drug Deliv Rev       Date:  2020-07-22       Impact factor: 15.470

8.  Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis.

Authors:  Hong Zhou; Haixin Qian
Journal:  Drug Des Devel Ther       Date:  2018-08-22       Impact factor: 4.162

Review 9.  Application of Halloysite Nanotubes in Cancer Therapy-A Review.

Authors:  Anna Karewicz; Adrianna Machowska; Martyna Kasprzyk; Gabriela Ledwójcik
Journal:  Materials (Basel)       Date:  2021-05-29       Impact factor: 3.623

10.  Photoactivatable Surface-Functionalized Diatom Microalgae for Colorectal Cancer Targeted Delivery and Enhanced Cytotoxicity of Anticancer Complexes.

Authors:  Joachim Delasoie; Philippe Schiel; Sandra Vojnovic; Jasmina Nikodinovic-Runic; Fabio Zobi
Journal:  Pharmaceutics       Date:  2020-05-25       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.